HPGC Renmintongtai Pharmaceutical (SHSE:600829) Valuation Rank

View and export this data going back to 1994. Start your Free Trial

What is HPGC Renmintongtai Pharmaceutical Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

Three factors:
- Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
- Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
- Industry relative valuation
Companies without enough data is not ranked
Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

HPGC Renmintongtai Pharmaceutical Valuation Rank Related Terms

Thank you for viewing the detailed overview of HPGC Renmintongtai Pharmaceutical's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

HPGC Renmintongtai Pharmaceutical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HPGC Renmintongtai Pharmaceutical Corp (SHSE:600829) » Definitions » Valuation Rank

Traded in Other Exchanges

N/A

Address

No. 76 Hengshan Road, Nangang District, Heilongjiang Province, Harbin, CHN, 150076

Website

http://www.sanjing.com.cn

HPGC Renmintongtai Pharmaceutical Corp, formerly Harbin Pharm. Group Sanjing Pharmaceutical Shareholding Co Ltd is engaged in the production and sale of pharmaceuticals products in China.

Executives

Yue Xian Zhi	senior management
Zhang Li Jun	Director